Multi-omics analysis reveals that blood plasma contains specific proteins, metabolites, and extracellular vesicles that actively dictate aging pace across tissues, not merely reflect it. Young plasma components restore mitochondrial function, suppress inflammation, and extend lifespan when transferred to older animals, while plasma dilution removes pro-aging factors to reverse age-related decline. This finding transforms our understanding of aging from a passive cellular deterioration process to an actively regulated systemic phenomenon controlled by circulating factors. The therapeutic implications are profound—rather than targeting individual organs or pathways, interventions could focus on modifying blood composition itself. Plasma exchange therapies already show promise in neurodegenerative diseases, suggesting near-term clinical applications. However, the complexity of identifying which specific blood components drive these effects, and translating animal parabiosis studies to safe human interventions, remains challenging. This represents a paradigm shift toward viewing blood as the body's aging control center, opening entirely new avenues for rejuvenation medicine that could potentially coordinate anti-aging effects across multiple organ systems simultaneously.